Detalhe da pesquisa
1.
A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility.
Cell
; 165(2): 317-30, 2016 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27058664
2.
YAP1 is essential for malignant mesothelioma tumor maintenance.
BMC Cancer
; 22(1): 639, 2022 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35689194
3.
Production of the Bengamide Class of Marine Natural Products in Myxobacteria: Biosynthesis and Structure-Activity Relationships.
Angew Chem Int Ed Engl
; 54(51): 15560-4, 2015 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26514647
4.
TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC.
Pharmaceuticals (Basel)
; 16(4)2023 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37111311
5.
In vivo treatment with CPT-11 leads to differentiation of neuroblastoma xenografts and topoisomerase I alterations.
Cancer Res
; 64(9): 3223-9, 2004 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15126363
6.
Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844).
J Med Chem
; 59(15): 7066-74, 2016 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27355974
7.
The selective intravenous inhibitor of the MET tyrosine kinase SAR125844 inhibits tumor growth in MET-amplified cancer.
Mol Cancer Ther
; 14(2): 384-94, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25504634
8.
Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.
Clin Cancer Res
; 19(11): 2973-83, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23589177
9.
Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.
Clin Cancer Res
; 18(19): 5314-28, 2012 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22825584